In our AML cohort, we did see trends for associations, for example, mutations in DNMT3A , RUNX1, PTPN11, and WT1 , but these did not reach statistical significance.
← all excerpts
The Landscape of <i>KMT2A</i>-PTD AML: Concurrent Mutations, Gene Expression Signatures, and Clinical Outcome.
1
—
—